Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2025-12-24 @ 6:26 PM
NCT ID:
NCT05854368
Eligibility Criteria:
Inclusion Criteria:
Common
* 18 years old or highter
* written informed consent prior to any study procedure
* Affiliated to a social insurance system
Specific to patients with gastric lesions
* Untreated glandular atrophy (with or without intestinal metaplasia and/or dysplasia) and histologically diagnosed as of 2014
* Treatment naïve Gastric cancer (distal or proximal adenocarcinoma)
Exclusion Criteria:
Common
* Autoimmune disease or disease that impacts the immune system (e.g: HIV)
* Chronic inflammatory disease
* Known evolutive cancer (excluding gastric cancer)
* Treated in the last 3 months or currently treated with therapy that interferes with the immune system (e.g. immunosuppressive therapy)
* Current treatment with long-term corticosteroid therapy
* Current treatment with long-term nonsteroidal anti-inflammatory drugs
* Pregnant woman or breastfeeding
* Patient or healthy volunteer under legal protection (e.g. guardianship)
* Patient or healthy volunteer currently participating to a clinical trial evaluating either an experimental medical product or a medical device
* Patient or healthy volunteer currently in custody
Specific to Healthy Volunteer
* Known history of Helicobacter pylori infection
* Known history of gastric lesions (i.e. chronic gastritis, gastric atrophy, intestinal metaplasia, dysplasia and cancer)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05854368
Study Brief:
Protocol Section:
NCT05854368